Comparing the malignant and benign bone tumors, showed a significant increase in the PPARγ mRNA level in malignant (0.23 ± 0.13) vs. benign (0.16 ± 0.09) bone tumors (P = 0.0049) (Fig. 1b). This evidence concerns the gene PPARG and neoplasm.